Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD
11.88
+0.54 (4.76%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Development of Innovative Medicines | 503.99M | 19.06M | | 22.68M | | 3.84M |
Development of Innovative Medicines Growth | 2544.24% | - | | - | | - |
| 503.99M | 19.06M | | 22.68M | | 3.84M |
| 2544.24% | - | | - | | - |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 503.99M | 19.06M | | 22.68M | | 3.84M |
| 2544.24% | - | | - | | - |
| 503.99M | 19.06M | | 22.68M | | 3.84M |
| 2544.24% | - | | - | | - |
Source: S&P Global Market Intelligence.
